Dr. Reddy's Laboratories Limited (ADR)

General ticker "RDY" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - Specialty & Generic
  • Capitalization: $11.8B (TTM average)

Dr. Reddy's Laboratories Limited (ADR) does not follow the US Stock Market performance with the rate: -27.0%.

Estimated limits based on current volatility of 0.5%: low 12.14$, high 12.26$

Factors to consider:

  • Company pays dividends (annually): last record date 2026-07-09, amount 0.08$ (Y0.66%)
  • Total employees count: 5852 as of 2003
  • Price in estimated range
  • Earnings for 15 months up through Q1 (+1 year) are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-03-31 to 2027-03-31

  • 2025-03-31 to 2026-03-31 estimated range: [10.66$, 17.06$]
  • 2026-03-31 to 2027-03-31 estimated range: [11.06$, 17.58$]

Financial Metrics affecting the RDY estimates:

  • Positive: with PPE of 20.3 at the end of fiscal year the price was low
  • Positive: Operating profit margin, % of 22.07 > 18.77
  • Positive: 0.28 < Operating cash flow per share per price, % of 4.83
  • Negative: Industry earnings per price (median), % of 0 <= 0
  • Positive: Industry inventory ratio change (median), % of -0.80 <= -0.14
  • Negative: Shareholder equity ratio, % of 67.63 > 63.63
  • Negative: negative Industry operating income (median)
  • Negative: negative Industry operating cash flow (median)
  • Negative: Investing cash flow per share per price, % of -6.04 <= -4.49

Similar symbols

Short-term RDY quotes

Long-term RDY plot with estimates

Financial data

YTD 2023-03-31 2024-03-31 2025-03-31
Operating Revenue INR245,879.00MM INR279,164.00MM INR325,535.00MM
Operating Expenses INR188,735.00MM INR211,435.00MM INR253,692.00MM
Operating Income INR57,144.00MM INR67,729.00MM INR71,843.00MM
Non-Operating Income INR3,223.00MM INR4,141.00MM INR4,941.00MM
Interest Expense INR1,428.00MM INR1,711.00MM INR2,829.00MM
R&D Expense INR19,381.00MM INR22,873.00MM INR27,380.00MM
Income(Loss) INR60,367.00MM INR71,870.00MM INR76,784.00MM
Taxes INR15,300.00MM INR16,186.00MM INR19,539.00MM
Net Income(Loss)* INR45,067.00MM INR55,684.00MM INR56,544.00MM
Stockholders Equity INR230,991.00MM INR280,550.00MM INR333,388.00MM
Inventory INR48,670.00MM INR63,552.00MM INR71,085.00MM
Assets INR321,854.00MM INR387,518.00MM INR492,989.00MM
Operating Cash Flow INR58,875.00MM INR45,433.00MM INR46,428.00MM
Capital expenditure INR18,866.00MM INR27,435.00MM INR34,398.00MM
Investing Cash Flow INR-41,373.00MM INR-40,283.00MM INR-58,077.00MM
Financing Cash Flow INR-26,861.00MM INR-3,763.00MM INR18,911.00MM
Earnings Per Share** INR54.29 INR66.80 INR67.85
Ordinary share to ADR 1.00x 1.00x 1.00x

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.